A detailed history of Ewa, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Ewa, LLC holds 1,869 shares of ABBV stock, worth $336,420. This represents 0.11% of its overall portfolio holdings.

Number of Shares
1,869
Previous 1,631 14.59%
Holding current value
$336,420
Previous $282 Million 12.32%
% of portfolio
0.11%
Previous 0.12%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$163.84 - $199.33 $38,993 - $47,440
238 Added 14.59%
1,869 $317 Million
Q2 2024

Jul 24, 2024

BUY
$154.79 - $180.76 $14,705 - $17,172
95 Added 6.18%
1,631 $282 Million
Q1 2024

May 13, 2024

BUY
$159.82 - $182.1 $245,483 - $279,705
1,536 New
1,536 $247 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Ewa, LLC Portfolio

Follow Ewa, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ewa, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ewa, LLC with notifications on news.